- In Memoriam
- About
- Apply
- People
- Education
- Events
- Articles
-
News
News Fatty Liver Foundation Opens Applications for Year 2 of the Dr. Stephen A. Harrison Patient Advocacy Fellowship Harrison Fellowship Highlights Patient Advocate Engagement at Liver Forum 20 Harrison Fellows Engage at 10th Annual MASH-TAG Conference Harrison Fellows Convene at AASLD’s The Liver Meeting® 2025 The Dr. Stephen A. Harrison Patient Advocacy Fellowship Program on Surfing the MASH Tsunami Fatty Liver Foundation to Introduce Dr. Stephen A. Harrison Patient Advocacy Fellowship at Liver Forum 19 in Paris, France Fatty Liver Foundation Announces Inaugural Cohort of the Dr. Stephen A. Harrison Patient Advocacy Fellowship Fatty Liver Foundation Launches Groundbreaking Patient Advocacy Fellowship Honoring Dr. Stephen A. Harrison
- FAQ
- Contact
Program Details
- Program Details
Answer
-
What is the duration of the Fellowship?
- The Fellowship runs from September 2026 to September 2027.
-
Is this a paid Fellowship?
- No, Fellows will not receive direct financial compensation. However, the Fellowship covers the costs associated with participation, including access to educational resources and travel to key conferences focused on SLD. The final schedule of events and educational sessions will be confirmed with selected candidates.
-
What kind of time commitment is expected?
- Fellows should be prepared for a part-time commitment that may vary week to week, depending on the program’s activities and milestones. The schedule will be coordinated with the program manager. In addition to ongoing responsibilities, Fellows are also expected to participate in scheduled face-to-face events.
- The learning sessions are scheduled based on the availability of mentors, most of whom are based in the United States. We aim to accommodate other time zones as much as possible; however, for participants in the UK and EU, this typically means sessions take place in the evening hours. Recordings are shared when available.
-
What support will Fellows receive?
- Fellows receive mentorship, training, networking opportunities, and access to resources. According to the confirmed schedule, they will also participate in flagship face-to-face conferences on SLD research and be introduced to key opinion leaders and companies in MASH drug development. As part of our ongoing commitment to elevating patient and advocate voices, we will also notify Fellowship alumni of relevant paid opportunities as they arise, including invitations to serve on advisory boards, speak at conferences, or contribute to research and policy initiatives.
-
What is the language of the Fellowship program?
- The Fellowship program is conducted in English. All sessions, materials, and communications will be provided in English, so applicants should be comfortable reading, writing, and participating in discussions in English.
- Is the Fellowship focused on a specific geographic region?
-
- The Fellowship is primarily focused on the U.S. context, including clinical research, regulatory processes, and healthcare systems. At the same time, we welcome applications from the United Kingdom, the European Union, and Canada, and aim to make the content relevant to a broader international audience where possible.